001     1019094
005     20250204113740.0
024 7 _ |a 10.1016/j.bpsc.2023.11.001
|2 doi
024 7 _ |a 2451-9022
|2 ISSN
024 7 _ |a 2451-9030
|2 ISSN
024 7 _ |a 10.34734/FZJ-2023-05147
|2 datacite_doi
024 7 _ |a 38000716
|2 pmid
024 7 _ |a WOS:001207230300001
|2 WOS
037 _ _ |a FZJ-2023-05147
082 _ _ |a 610
100 1 _ |a Pergola, Giulio
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a A miR-137-related biological pathway of risk for Schizophrenia is associated with human brain emotion processing
260 _ _ |a Amsterdam [u.a.]
|c 2024
|b Elsevier Inc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1710150293_11296
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a BackgroundMiR-137 is a microRNA involved in brain development, regulating neurogenesis and neuronal maturation. Genome-Wide Association Studies implicate miR-137 in schizophrenia risk but do not explain its involvement in brain function and underlying biology. Polygenic risk for schizophrenia mediated by miR-137 targets is associated with working memory, although other evidence points to emotion processing. We characterized the functional brain correlates of miR-137 target genes associated with schizophrenia while disentangling previously reported associations of miR-137 targets with working memory and emotion processing.MethodsUsing RNA-sequencing data from postmortem prefrontal cortex (N=522), we identified a co-expression gene set enriched for miR-137 targets and schizophrenia risk genes. We validated the relationship of this set to miR-137 in-vitro by manipulating miR-137 expression in neuroblastoma cells. We translated this gene set into polygenic scores of co-expression prediction and associated them with fMRI activation in healthy volunteers (N1=214; N2=136; N3=2,075; N4=1,800) and with short-term treatment response in patients with schizophrenia (N=427).ResultsIn 4,652 human subjects, we found that (i) schizophrenia risk genes are co-expressed in a biologically validated set enriched for miR-137 targets, (ii) increased expression of miR-137 target risk genes is mediated by low prefrontal miR-137 expression, (iii) alleles predicting greater gene-set co-expression are associated with greater prefrontal activation during emotion processing in three independent healthy cohorts (N1-2-3), in interaction with age (N4), (iv) these alleles predict less improvement in negative symptoms following antipsychotic treatment in patients with schizophrenia.
536 _ _ |a 5252 - Brain Dysfunction and Plasticity (POF4-525)
|0 G:(DE-HGF)POF4-5252
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Rampino, Antonio
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Sportelli, Leonardo
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Borcuk, Christopher James
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Passiatore, Roberta
|0 P:(DE-Juel1)195972
|b 4
700 1 _ |a Di Carlo, Pasquale
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Marakhovskaia, Aleksandra
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Fazio, Leonardo
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Amoroso, Nicola
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Castro, Mariana Nair
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Domenici, Enrico
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Gennarelli, Massimo
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Khlghatyan, Jivan
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Kikidis, Gianluca Christos
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Lella, Annalisa
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Magri, Chiara
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Monaco, Alfonso
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Papalino, Marco
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Parihar, Madhur
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Popolizio, Teresa
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Quarto, Tiziana
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Romano, Raffaella
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Torretta, Silvia
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Valsecchi, Paolo
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Zunuer, Hediche
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Blasi, Giuseppe
|0 P:(DE-HGF)0
|b 25
700 1 _ |a Dukart, Jürgen
|0 P:(DE-Juel1)177727
|b 26
700 1 _ |a Beaulieu, Jean Martin
|0 P:(DE-HGF)0
|b 27
700 1 _ |a Bertolino, Alessandro
|0 P:(DE-HGF)0
|b 28
773 _ _ |a 10.1016/j.bpsc.2023.11.001
|g p. S2451902223003117
|0 PERI:(DE-600)2879089-3
|n 3
|p 356-366
|t Biological psychiatry / Cognitive neuroscience and neuroimaging
|v 9
|y 2024
|x 2451-9022
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/1019094/files/1-s2.0-S2451902223003117-main.pdf
856 4 _ |y OpenAccess
|x icon
|u https://juser.fz-juelich.de/record/1019094/files/1-s2.0-S2451902223003117-main.gif?subformat=icon
856 4 _ |y OpenAccess
|x icon-1440
|u https://juser.fz-juelich.de/record/1019094/files/1-s2.0-S2451902223003117-main.jpg?subformat=icon-1440
856 4 _ |y OpenAccess
|x icon-180
|u https://juser.fz-juelich.de/record/1019094/files/1-s2.0-S2451902223003117-main.jpg?subformat=icon-180
856 4 _ |y OpenAccess
|x icon-640
|u https://juser.fz-juelich.de/record/1019094/files/1-s2.0-S2451902223003117-main.jpg?subformat=icon-640
909 C O |o oai:juser.fz-juelich.de:1019094
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Giulio Pergola, PhD, Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari Aldo Moro
|0 I:(DE-HGF)0
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)195972
910 1 _ |a Group of Psychiatric Neuroscience, Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro
|0 I:(DE-HGF)0
|b 4
|6 P:(DE-Juel1)195972
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 26
|6 P:(DE-Juel1)177727
910 1 _ |a HHU Düsseldorf
|0 I:(DE-HGF)0
|b 26
|6 P:(DE-Juel1)177727
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5252
|x 0
914 1 _ |y 2024
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-06
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BIOL PSYCHIAT-COGN N : 2022
|d 2024-12-06
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b BIOL PSYCHIAT-COGN N : 2022
|d 2024-12-06
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-7-20090406
|k INM-7
|l Gehirn & Verhalten
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-7-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21